Download Files:
CKD-519
SKU
HY-116078-10 mg
Category Reference compound
Tags Cardiovascular Disease, CETP, Metabolic Enzyme/Protease
$450 – $4,500
Products Details
Product Description
– CKD-519 is a selective and potent cholesteryl ester transfer protein (CETP) inhibitor, which inhibits CETP-mediated transfer of cholesteryl ester in human serum with an IC50 of 2.3 nM[1].
Web ID
– HY-116078
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C31H34F7NO3
References
– [1]Kim CO, et al. Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects. Drug Des Devel Ther. 2016 Nov 15;10:3763-3770.
CAS Number
– 1402796-27-3
Molecular Weight
– 601.60
Compound Purity
– 99.65
SMILES
– C[C@H]1[C@H](OC(N1CC2=C(C3=C(C=C(C(C(C)C)=C3)F)OC)CCC(C)(C2)C)=O)C4=CC(C(F)(F)F)=CC(C(F)(F)F)=C4
Clinical Information
– Phase 2
Research Area
– Cardiovascular Disease
Solubility
– DMSO : 66.67 mg/mL (ultrasonic)
Target
– CETP
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.